Plain-English translation of NCT07410507 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called , which you would inject yourself under the skin, to see if it helps improve schizophrenia symptoms when added to the medications you're already taking. Researchers want to learn whether this treatment is safe and whether it reduces symptom flare-ups and relapses. About 450 people with schizophrenia will participate.
Standard schizophrenia medications help many people, but some patients still experience relapses or ongoing symptoms. This medication is being tested to see if adding it to existing treatments can provide better control of schizophrenia and prevent relapses.
You likely qualify if…
You likely don't qualify if…
You would first go through a screening period of about one month to confirm you're eligible. Then you would either receive the new injectable medication or a placebo (a fake injection) along with your regular schizophrenia medications for up to 12 months. After that, there's a 2-month follow-up period, making your total involvement about 15 months. You'll need to give yourself injections, keep records, attend clinic visits, and complete questionnaires as part of the study.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States